Zions Bancorporation’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $22.5K | Buy |
304
+20
| +7% | +$1.4K | ﹤0.01% | 497 |
|
|
2024
Q3 | $18.7K | Sell |
284
-3,026
| -91% | -$220K | ﹤0.01% | 527 |
|
|
2024
Q2 | $306K | Sell |
3,310
-821
| -20% | -$72.7K | 0.02% | 282 |
|
|
2024
Q1 | $395K | Buy |
4,131
+3,645
| +750% | +$306K | 0.03% | 272 |
|
|
2023
Q4 | $37.1K | Sell |
486
-198
| -29% | -$13.8K | ﹤0.01% | 448 |
|
|
2023
Q3 | $47.4K | Sell |
684
-7
| -1% | -$563 | ﹤0.01% | 396 |
|
|
2023
Q2 | $65.2K | Sell |
691
-38
| -5% | -$3.3K | 0.01% | 369 |
|
|
2023
Q1 | $60.3K | Sell |
729
-15
| -2% | -$1.18K | 0.01% | 402 |
|
|
2022
Q4 | $55.5K | Buy |
744
+204
| +38% | +$15.7K | ﹤0.01% | 430 |
|
|
2022
Q3 | $45K | Sell |
540
-737
| -58% | -$70.9K | ﹤0.01% | 435 |
|
|
2022
Q2 | $121K | Sell |
1,277
-461
| -27% | -$47.7K | 0.01% | 358 |
|
|
2022
Q1 | $204K | Buy |
1,738
+448
| +35% | +$50.3K | 0.02% | 320 |
|
|
2021
Q4 | $167K | Sell |
1,290
-2,147
| -62% | -$250K | 0.01% | 318 |
|
|
2021
Q3 | $389K | Sell |
3,437
-431
| -11% | -$49.2K | 0.04% | 235 |
|
|
2021
Q2 | $401K | Sell |
3,868
-761
| -16% | -$71.7K | 0.04% | 205 |
|
|
2021
Q1 | $387K | Buy |
4,629
+2,635
| +132% | +$223K | 0.04% | 177 |
|
|
2020
Q4 | $182K | Buy |
1,994
+8
| +0.4% | +$664 | 0.02% | 271 |
|
|
2020
Q3 | $158K | Hold |
1,986
| – | – | 0.02% | 253 |
|
|
2020
Q2 | $137K | Buy |
1,986
+27
| +1% | +$1.92K | 0.02% | 253 |
|
|
2020
Q1 | $123K | Sell |
1,959
-354
| -15% | -$25.5K | 0.02% | 238 |
|
|
2019
Q4 | $180K | Sell |
2,313
-45
| -2% | -$3.51K | 0.03% | 240 |
|
|
2019
Q3 | $173K | Buy |
+2,358
| New | +$166K | 0.02% | 272 |
|
|
2018
Q4 | – | Sell |
-9,618
| Closed | -$558K | – | 580 |
|
|
2018
Q3 | $558K | Buy |
+9,618
| New | +$470K | 0.13% | 86 |
|
|
2017
Q4 | – | Sell |
-12,243
| Closed | -$447K | – | 727 |
|
|
2017
Q3 | $447K | Buy |
12,243
+12,144
| +12,267% | +$463K | 0.06% | 166 |
|
|
2017
Q2 | $4K | Sell |
99
-6
| -6% | -$219 | ﹤0.01% | 467 |
|
|
2017
Q1 | $4K | Sell |
105
-213
| -67% | -$6.67K | ﹤0.01% | 527 |
|
|
2016
Q4 | $10K | Buy |
318
+102
| +47% | +$3.31K | ﹤0.01% | 507 |
|
|
2016
Q3 | $8K | Sell |
216
-3
| -1% | -$113 | ﹤0.01% | 521 |
|
|
2016
Q2 | $8K | Buy |
219
+3
| +1% | +$103 | ﹤0.01% | 476 |
|
|
2016
Q1 | $8K | Sell |
216
-24
| -10% | -$662 | ﹤0.01% | 558 |
|
|
2015
Q4 | $7K | Buy |
240
+24
| +11% | +$623 | ﹤0.01% | 543 |
|
|
2015
Q3 | $6K | Buy |
+216
| New | +$5.21K | ﹤0.01% | 575 |
|
|
2015
Q2 | – | Sell |
-258
| Closed | -$7K | – | 415 |
|
|
2015
Q1 | $7K | Buy |
+258
| New | +$5.79K | ﹤0.01% | 591 |
|
Other funds holding EW
Zions Bancorporation's EW Position: Q4 2024 in Review
Zions Bancorporation increased its Edwards Lifesciences (EW) stake by 7% in Q4 2024, buying an estimated $1.4K and bringing the position to 304 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #497.
Zions Bancorporation first reported a position in EW in Q1 2015 and has held it in 33 quarters since. The position peaked at $558K in Q3 2018. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Zions Bancorporation held 304 shares of Edwards Lifesciences worth $22.5K as of Q4 2024.
- Zions Bancorporation bought 20 Edwards Lifesciences shares in Q4 2024, an estimated $1.4K.
- Edwards Lifesciences made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #497 holding.
- Zions Bancorporation first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 33 quarters since.
- Zions Bancorporation's Edwards Lifesciences position peaked at $558K in Q3 2018.
- 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.